“After having achieved my goal of successfully identifying and acquiring a FDA cleared, CLIA waived product that offers CLX the opportunity to become market leader in an important healthcare sector, I am returning to my personal business of executive coaching and leadership development,” commented Leonard. “I continue to believe that the ThyroTest product has a great future and wish CLX great success in the next steps of its launch.”
Chairman Patrick Edgerton stated, “We would like to thank Vera Leonard for her service to the company and wish her nothing but the best in her future endeavors.”